We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Trends in Health-Care Utilization at the End of Life Among Patients With Hematologic Malignancies in a Middle-Income Country: Challenges and Opportunities in Brazil.
- Authors
Soares, Luiz Guilherme L.; Gomes, Renato Vieira; Japiassu, André M.
- Abstract
Patients with hematologic malignancies (HMs) often receive poor-quality end-of-life care. This study aimed to identify trends in end-of-life care among patients with HM in Brazil. We conducted a retrospective cohort study (2015-2018) of patients who died with HM, using electronic medical records linked to health insurance databank, to evaluate outcomes consistent with health-care resource utilization at the end of life. Among 111 patients with HM, in the last 30 days of life, we found high rates of emergency department visits (67%, n = 75), intensive care unit admissions (56%, n = 62), acute renal replacement therapy (10%, n = 11), blood transfusions (45%, n = 50), and medical imaging utilization (59%, n = 66). Patients received an average of 13 days of inpatient care and the majority of them died in the hospital (53%, n = 58). We also found that almost 40% of patients (38%, n = 42) used chemotherapy in the last 14 days of life. These patients were more likely to be male (64% vs 22%; P <.001), to receive blood transfusions (57% vs 38%; P =.05), and to die in the hospital (76% vs 39%; P =.009) than patients who did not use chemotherapy in the last 14 days of life. This study suggests that patients with HM have high rates of health-care utilization at the end of life in Brazil. Patients who used chemotherapy in the last 14 days of life were more likely to receive blood transfusions and to die in the hospital.
- Subjects
BRAZIL; BLOOD transfusion; CANCER chemotherapy; CANCER patients; DIAGNOSTIC imaging; HOSPITAL care; HOSPITAL admission &; discharge; KIDNEY diseases; LEUKEMIA; LYMPHOMAS; MEDICAL appointments; MEDICAL care use; MEDICAL records; MULTIPLE myeloma; PALLIATIVE treatment; PATIENTS; T-test (Statistics); THERAPEUTICS; RETROSPECTIVE studies; DATA analysis software; DESCRIPTIVE statistics; HEMATOLOGIC malignancies; ACQUISITION of data methodology; KRUSKAL-Wallis Test
- Publication
American Journal of Hospice & Palliative Medicine, 2019, Vol 36, Issue 9, p775
- ISSN
1049-9091
- Publication type
Article
- DOI
10.1177/1049909119828086